INOZYME PHARMA, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 97 rows, 97 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2025-07-01: Reporting owner Subramanian Sanjay; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2025-07-01: Reporting owner Subramanian Sanjay; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2025-07-01: Reporting owner Subramanian Sanjay; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2025-07-01: Reporting owner Winton Matthew; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-07-01 | Subramanian Sanjay Officer (SVP, CFO & Head of BD) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −180,000 0 owned after | $3.96 exercise price | 2025-07-03 | |
| 2025-07-01 | Subramanian Sanjay Officer (SVP, CFO & Head of BD) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −135,000 0 owned after | $3.30 exercise price | 2025-07-03 | |
| 2025-07-01 | Subramanian Sanjay Officer (SVP, CFO & Head of BD) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −145,000 0 owned after | $1.06 exercise price | 2025-07-03 | |
| 2025-07-01 | Winton Matthew Officer (COO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −145,000 0 owned after | $1.06 exercise price | 2025-07-03 | |
| 2025-07-01 | Bolte Axel Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −234,176 0 owned after | $2.02 exercise price | 2025-07-03 | |
| 2025-07-01 | Bolte Axel Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −159,187 0 owned after | $2.77 exercise price | 2025-07-03 | |
| 2025-07-01 | Sullivan Lynne Marie Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −28,368 0 owned after | $2.77 exercise price | 2025-07-03 | |
| 2025-07-01 | Treco Douglas A Director, Officer (CEO & Chairman) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −86,979 0 owned after | $2.77 exercise price | 2025-07-03 | |
| 2025-07-01 | Treco Douglas A Director, Officer (CEO & Chairman) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −400,000 0 owned after | $1.06 exercise price | 2025-07-03 | |
| 2025-05-15 | Bolte Axel Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −152,823 0 owned after | $0.98 exercise price | 2025-05-20 | |
| 2025-05-15 | Bolte Axel Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,407 0 owned after | $0.98 exercise price | 2025-05-20 | |
| 2025-03-11 | Subramanian Sanjay Officer (SVP, CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +145,000 145,000 owned after | $1.06 exercise price | 2025-03-17 | |
| 2025-03-11 | Winton Matthew Officer (COO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +145,000 145,000 owned after | $1.06 exercise price | 2025-03-17 | |
| 2025-03-11 | Treco Douglas A Director, Officer (CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +400,000 400,000 owned after | $1.06 exercise price | 2025-03-17 | |
| 2024-10-03 | Harris Erik Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,000 56,000 owned after | $5.06 exercise price | 2024-10-07 | |
| 2024-06-18 | Mathers Edward T Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,000 28,000 owned after | $4.40 exercise price | 2024-06-20 | |
| 2024-06-18 | Hopfner Robert Lorne Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,000 28,000 owned after | $4.40 exercise price | 2024-06-20 | |
| 2024-06-18 | DIAZ REINALDO M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,000 28,000 owned after | $4.40 exercise price | 2024-06-20 | |
| 2024-06-18 | Sullivan Lynne Marie Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,000 28,000 owned after | $4.40 exercise price | 2024-06-20 | |
| 2024-06-18 | Bhagat Sarah M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,000 28,000 owned after | $4.40 exercise price | 2024-06-20 | |
| 2024-06-18 | Bolte Axel Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,000 28,000 owned after | $4.40 exercise price | 2024-06-20 | |
| 2024-06-18 | Edwards Martin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,000 28,000 owned after | $4.40 exercise price | 2024-06-20 | |
| 2024-03-13 | Winton Matthew Officer (COO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +175,000 175,000 owned after | $5.77 exercise price | 2024-03-15 | |
| 2024-03-13 | Treco Douglas A Director, Officer (CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $5.77 exercise price | 2024-03-15 | |
| 2024-03-13 | Subramanian Sanjay Officer (SVP, CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +165,000 165,000 owned after | $5.77 exercise price | 2024-03-15 | |
| 2023-06-13 | Mathers Edward T Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,000 16,000 owned after | $6.18 exercise price | 2023-06-15 | |
| 2023-06-13 | Sullivan Lynne Marie Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,000 16,000 owned after | $6.18 exercise price | 2023-06-15 | |
| 2023-06-13 | DIAZ REINALDO M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,000 16,000 owned after | $6.18 exercise price | 2023-06-15 | |
| 2023-06-13 | Hopfner Robert Lorne Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,000 16,000 owned after | $6.18 exercise price | 2023-06-15 | |
| 2023-06-13 | Edwards Martin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,000 16,000 owned after | $6.18 exercise price | 2023-06-15 | |
| 2023-06-13 | Bolte Axel Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,000 16,000 owned after | $6.18 exercise price | 2023-06-15 | |
| 2023-06-13 | Bhagat Sarah M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,000 16,000 owned after | $6.18 exercise price | 2023-06-15 | |
| 2023-05-01 | Bolte Axel Director | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $5.81 exercise price | 2023-05-03 | |
| 2023-04-03 | Winton Matthew Officer (COO) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $5.39 exercise price | 2023-04-04 | |
| 2023-04-01 | Treco Douglas A Director, Officer (CEO) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +800,000 800,000 owned after | $5.73 exercise price | 2023-04-04 | |
| 2023-03-23 | Subramanian Sanjay Officer (SVP, CFO) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +135,000 135,000 owned after | $3.30 exercise price | 2023-03-27 | |
| 2022-06-10 | Mathers Edward T Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $4.38 exercise price | 2022-06-14 | |
| 2022-06-10 | Treco Douglas A Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $4.38 exercise price | 2022-06-14 | |
| 2022-06-10 | Sullivan Lynne Marie Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $4.38 exercise price | 2022-06-14 | |
| 2022-06-10 | Hopfner Robert Lorne Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $4.38 exercise price | 2022-06-14 | |
| 2022-06-10 | Edwards Martin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $4.38 exercise price | 2022-06-14 | |
| 2022-06-10 | DIAZ REINALDO M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $4.38 exercise price | 2022-06-14 | |
| 2022-06-10 | Bhagat Sarah M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $4.38 exercise price | 2022-06-14 | |
| 2022-03-21 | Subramanian Sanjay Officer (SVP, CFO) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +180,000 180,000 owned after | $3.96 exercise price | 2022-03-22 | |
| 2022-02-24 | Bolte Axel Director, Officer (Chief Executive Officer) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +275,000 275,000 owned after | $5.78 exercise price | 2022-02-28 | |
| 2022-02-24 | Bjarke Henric Bjorn Officer (SVP, COO) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +115,000 115,000 owned after | $5.78 exercise price | 2022-02-28 | |
| 2021-06-24 | Bolte Axel Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −66,788 100,480 owned after | $0.98 exercise price | 2021-06-25 | |
| 2021-06-23 | Bhagat Sarah M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $17.12 exercise price | 2021-06-25 | |
| 2021-06-23 | Mathers Edward T Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $17.12 exercise price | 2021-06-24 | |
| 2021-06-23 | Edwards Martin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $17.12 exercise price | 2021-06-24 | |
| 2021-06-23 | Treco Douglas A Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $17.12 exercise price | 2021-06-24 | |
| 2021-06-23 | Sullivan Lynne Marie Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $17.12 exercise price | 2021-06-24 | |
| 2021-06-23 | Hopfner Robert Lorne Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $17.12 exercise price | 2021-06-24 | |
| 2021-06-23 | DIAZ REINALDO M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $17.12 exercise price | 2021-06-24 | |
| 2021-06-23 | Inozyme Pharma, Inc. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $17.12 exercise price | 2021-06-24 | |
| 2021-05-17 | DiPalma Stephen J. Officer (Interim CFO) | 4 | Stock option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $15.90 exercise price | 2021-05-18 | |
| 2021-03-24 | Basso Stephen Officer (SVP Finance (PFO)) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,000 13,000 owned after | $17.77 exercise price | 2021-03-25 | |
| 2021-03-04 | Jungles Steven J Officer (SVP, CTO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +42,000 42,000 owned after | $19.78 exercise price | 2021-03-17 | |
| 2021-03-04 | Bolte Axel Director, Officer (Chief Executive Officer) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +117,000 117,000 owned after | $19.78 exercise price | 2021-03-17 | |
| 2021-03-04 | Bjarke Henric Bjorn Officer (SVP, COO) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,000 51,000 owned after | $19.78 exercise price | 2021-03-17 | |
| 2021-03-04 | Basso Stephen Officer (SVP Finance (PFO)) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,000 27,000 owned after | $19.78 exercise price | 2021-03-17 | |
| 2021-02-02 | Wenkert Deborah Officer (SVP, CMO) | 4 | Stock option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $22.61 exercise price | 2021-02-04 | |
| 2021-01-13 | Jungles Steven J Officer (SVP, CTO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,315 44,315 owned after | $2.77 exercise price | 2021-01-14 | |
| 2021-01-13 | Huertas Pedro Officer (SVP, CMO) | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,074 36,074 owned after | $2.77 exercise price | 2021-01-14 | |
| 2021-01-13 | Bjarke Henric Bjorn Officer (SVP, COO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,105 51,105 owned after | $2.77 exercise price | 2021-01-14 | |
| 2021-01-13 | Basso Stephen Officer (SVP Finance (PFO)) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,794 41,794 owned after | $2.77 exercise price | 2021-01-14 | |
| 2021-01-13 | Bolte Axel Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +159,187 159,187 owned after | $2.77 exercise price | 2021-01-14 | |
| 2021-01-13 | Bolte Axel Director, Officer (Chief Executive Officer) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +66,788 66,788 owned after | $16.00 exercise price | 2021-01-14 | |
| 2020-07-23 | Mathers Edward T Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $16.00 exercise price | 2020-07-24 | |
| 2020-07-23 | Huertas Pedro Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +43,951 43,951 owned after | $16.00 exercise price | 2020-07-24 | |
| 2020-07-23 | Treco Douglas A Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $16.00 exercise price | 2020-07-24 | |
| 2020-07-23 | Edwards Martin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $16.00 exercise price | 2020-07-24 | |
| 2020-07-23 | Bjarke Henric Bjorn Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +32,905 32,905 owned after | $16.00 exercise price | 2020-07-24 | |
| 2020-07-23 | Bolte Axel Director, Officer (See Remarks), 10% Owner | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +287,706 287,706 owned after | $16.00 exercise price | 2020-07-24 | |
| 2020-07-23 | Hopfner Robert Lorne Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $16.00 exercise price | 2020-07-24 | |
| 2020-07-23 | DIAZ REINALDO M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $16.00 exercise price | 2020-07-24 | |
| 2020-07-23 | Sullivan Lynne Marie Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $16.00 exercise price | 2020-07-24 | |
| 2020-07-23 | Bhagat Sarah M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,367 9,367 owned after | $16.00 exercise price | 2020-07-24 | |
| 2020-07-23 | Basso Stephen Officer (Senior Vice President, Finance) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,433 27,433 owned after | $16.00 exercise price | 2020-07-24 | |
| 2020-07-23 holding as of filing | Jungles Steven J Officer (See Remarks) | 3 | Stock Option (right to buy) Derivative · Direct · (m) | Holding | $0.98 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Jungles Steven J Officer (See Remarks) | 3 | Stock Option (right to buy) Derivative · Direct · (m) | Holding | $2.02 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Jungles Steven J Officer (See Remarks) | 3 | Stock Option (right to buy) Derivative · Direct · (m) | Holding | $2.02 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Basso Stephen Officer (Senior Vice President, Finance) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $0.98 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Basso Stephen Officer (Senior Vice President, Finance) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $1.87 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Basso Stephen Officer (Senior Vice President, Finance) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $2.02 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Huertas Pedro Officer (See Remarks) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $2.02 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Schlessinger Joseph 10% Owner | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $0.98 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Schlessinger Joseph 10% Owner | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $2.02 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Bjarke Henric Bjorn Officer (See Remarks) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $0.98 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Bjarke Henric Bjorn Officer (See Remarks) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $2.02 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Sullivan Lynne Marie Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $2.77 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Treco Douglas A Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $2.77 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Bolte Axel Director, Officer (See Remarks), 10% Owner | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $0.98 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Bolte Axel Director, Officer (See Remarks), 10% Owner | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $0.98 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Bolte Axel Director, Officer (See Remarks), 10% Owner | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $2.02 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Braddock Demetrios 10% Owner | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $0.98 exercise price | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Braddock Demetrios 10% Owner | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $2.02 exercise price | 2020-07-23 |